Literature DB >> 25145337

The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model.

Mateja Erdani Kreft1, Urška Dragin Jerman, Eva Lasič, Tea Lanišnik Rižner, Neli Hevir-Kene, Luka Peternel, Katja Kristan.   

Abstract

PURPOSE: The further characterization of the cell line RPMI 2650 and the evaluation of different culture conditions for an in vitro model for nasal mucosa.
METHODS: Cells were cultured in media MEM or A-MEM at air-liquid (A-L) or liquid-liquid (L-L) interfaces for 1 or 3 weeks. Different cryopreservation methods and cell culture techniques were evaluated with immunolabelling of junctional proteins, ultrastructural analysis using electron microscopy, transepithelial electrical resistance (TEER) measurements, permeation studies with dextran and jacalin, and gene expression profiling of 84 drug transporters.
RESULTS: Cell proliferation and differentiation depended on the used medium. The established epithelia expressed occludin, claudin-1, and E-cadherin under all conditions. Cells grown at the A-L interface formed more layers and exhibited a higher TEER and lower dextran and jacalin permeability than at the L-L interface, where cells morphologically exhibited a more differentiated phenotype. The expression of ABC and SLC transporters depended on culture duration and interface.
CONCLUSIONS: The RPMI 2650 cells form a polarized epithelium resembling nasal mucosa. However, different culture conditions have a significant effect on cell ultrastructure, barrier integrity, and gene expression, and should be considered when using this cell line as an in vitro model for drug permeability studies and screening of nasal drug candidates.

Entities:  

Mesh:

Year:  2014        PMID: 25145337     DOI: 10.1007/s11095-014-1494-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

Review 1.  The use of cultured epithelial and endothelial cells for drug transport and metabolism studies.

Authors:  K L Audus; R L Bartel; I J Hidalgo; R T Borchardt
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

2.  Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability.

Authors:  Levente Kürti; Szilvia Veszelka; Alexandra Bocsik; Béla Ozsvári; László G Puskás; Agnes Kittel; Piroska Szabó-Révész; Mária A Deli
Journal:  Cytotechnology       Date:  2012-09-02       Impact factor: 2.058

3.  Human tumor cell line with a quasi-diploid karyotype (RPMI 2650).

Authors:  P S Moorhead
Journal:  Exp Cell Res       Date:  1965-08       Impact factor: 3.905

4.  Cultivation of RPMI 2650 cells as an in-vitro model for human transmucosal nasal drug absorption studies: optimization of selected culture conditions.

Authors:  Stephan Reichl; Karin Becker
Journal:  J Pharm Pharmacol       Date:  2012-05-23       Impact factor: 3.765

5.  CFTR, MDR1, and MRP1 immunolocalization in normal human nasal respiratory mucosa.

Authors:  M A Wioland; J Fleury-Feith; P Corlieu; F Commo; G Monceaux; J Lacau-St-Guily; J F Bernaudin
Journal:  J Histochem Cytochem       Date:  2000-09       Impact factor: 2.479

6.  Evaluation of the human cell line RPMI 2650 as an in vitro nasal model.

Authors:  A De Fraissinette; R Brun; H Felix; J Vonderscher; A Rummelt
Journal:  Rhinology       Date:  1995-12       Impact factor: 3.681

7.  HLA-DR- and CD11c-positive dendritic cells penetrate beyond well-developed epithelial tight junctions in human nasal mucosa of allergic rhinitis.

Authors:  Ken-Ichi Takano; Takashi Kojima; Mitsuru Go; Masaki Murata; Shingo Ichimiya; Tetsuo Himi; Norimasa Sawada
Journal:  J Histochem Cytochem       Date:  2005-05       Impact factor: 2.479

8.  Drug transporter expression and localization in rat nasal respiratory and olfactory mucosa and olfactory bulb.

Authors:  Mary Beth Genter; Mansi Krishan; Lisa M Augustine; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2010-07-21       Impact factor: 3.922

9.  Thymic stromal lymphopoietin enhances tight-junction barrier function of human nasal epithelial cells.

Authors:  Ryuta Kamekura; Takashi Kojima; Jun-ichi Koizumi; Noriko Ogasawara; Makoto Kurose; Mitsuru Go; Atsushi Harimaya; Masaki Murata; Satoshi Tanaka; Hideki Chiba; Tetsuo Himi; Norimasa Sawada
Journal:  Cell Tissue Res       Date:  2009-09-09       Impact factor: 5.249

10.  Characterization of human type I and type II IMP dehydrogenases.

Authors:  S F Carr; E Papp; J C Wu; Y Natsumeda
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

View more
  11 in total

Review 1.  Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?

Authors:  Clément Mercier; Nathalie Perek; Xavier Delavenne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

2.  Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins.

Authors:  Bettina Gabold; Friederike Adams; Sophie Brameyer; Kirsten Jung; Christian L Ried; Thomas Merdan; Olivia M Merkel
Journal:  Drug Deliv Transl Res       Date:  2022-10-07       Impact factor: 5.671

3.  Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.

Authors:  Domizia Baldassi; Bettina Gabold; Olivia Merkel
Journal:  Adv Nanobiomed Res       Date:  2021-05-06

4.  Enhanced nasal drug delivery efficiency by increasing mechanical loading using hypergravity.

Authors:  Dongjoo Kim; Young Hyo Kim; Soonjo Kwon
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

5.  Development of a Novel ex vivo Nasal Epithelial Cell Model Supporting Colonization With Human Nasal Microbiota.

Authors:  Derald D Charles; James R Fisher; Sarah M Hoskinson; Audrie A Medina-Colorado; Yi C Shen; Mohamad R Chaaban; Steven G Widen; Tonyia D Eaves-Pyles; Carrie A Maxwell; Aaron L Miller; Vsevolod L Popov; Richard B Pyles
Journal:  Front Cell Infect Microbiol       Date:  2019-05-21       Impact factor: 5.293

6.  Standardization of esophageal adenocarcinoma in vitro model and its applicability for model drug testing.

Authors:  Larisa Tratnjek; Nadica Sibinovska; Slavko Kralj; Darko Makovec; Katja Kristan; Mateja Erdani Kreft
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

7.  Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations.

Authors:  Nadica Sibinovska; Simon Žakelj; Jurij Trontelj; Katja Kristan
Journal:  Pharmaceutics       Date:  2022-02-06       Impact factor: 6.321

8.  Human Multi-Compartment Airways-on-Chip Platform for Emulating Respiratory Airborne Transmission: From Nose to Pulmonary Acini.

Authors:  Eliram Nof; Hikaia Zidan; Arbel Artzy-Schnirman; Odelia Mouhadeb; Margarita Beckerman; Saurabh Bhardwaj; Shani Elias-Kirma; Didi Gur; Adi Beth-Din; Shulamit Levenberg; Netanel Korin; Arie Ordentlich; Josué Sznitman
Journal:  Front Physiol       Date:  2022-03-08       Impact factor: 4.566

9.  Effect of High, Medium, and Low Molecular Weight Hyaluronan on Inflammation and Oxidative Stress in an In Vitro Model of Human Nasal Epithelial Cells.

Authors:  Giusy Daniela Albano; Anna Bonanno; Luca Cavalieri; Eleonora Ingrassia; Caterina Di Sano; Liboria Siena; Loredana Riccobono; Rosalia Gagliardo; Mirella Profita
Journal:  Mediators Inflamm       Date:  2016-04-24       Impact factor: 4.711

Review 10.  Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.

Authors:  Oleg O Glebov
Journal:  FEBS J       Date:  2020-06-02       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.